title: Glucocorticoids stimulate endolymphatic water reabsorption in inner ear through aquaporin 3 regulation.
abstract: Menière's disease, clinically characterized by fluctuating, recurrent, and invalidating vertigo, hearing loss, and tinnitus, is linked to an increase in endolymph volume, the so-called endolymphatic hydrops. Since dysregulation of water transport could account for the generation of this hydrops, we investigated the role of aquaporin 3 (AQP3) in water transport into endolymph, the K-rich, hyperosmotic fluid that bathes the apical ciliated membrane of sensory cells, and we studied the regulatory effect of dexamethasone upon AQP3 expression and water fluxes. The different AQP subtypes were identified in inner ear by RT-PCR. AQP3 was localized in human utricle and mouse inner ear by immunohistochemistry and confocal microscopy. Unidirectional transepithelial water fluxes were studied by means of (3)H2O transport in murine EC5v vestibular cells cultured on filters, treated or not with dexamethasone (10(-7) M). The stimulatory effect of dexamethasone upon AQP3 expression was assessed in EC5v cells and in vivo in mice. AQP3 was unambiguously detected in human utricle and was highly expressed in both endolymph secretory structures of the mouse inner ear, and EC5v cells. We demonstrated that water reabsorption, from the apical (endolymphatic) to the basolateral (perilymphatic) compartments, was stimulated by dexamethasone in EC5v cells. This was accompanied by a glucocorticoid-dependent increase in AQP3 expression at both messenger RNA (mRNA) and protein level, presumably through glucocorticoid receptor-mediated AQP3 transcriptional activation. We show that glucocorticoids enhance AQP3 expression in human inner ear and stimulate endolymphatic water reabsorption. These findings should encourage further clinical trials evaluating glucocorticoids efficacy in Menière's disease.
authors.affiliation: Faculté de Médecine Paris Sud, Inserm U693, 63 rue Gabriel Péri, Le Kremlin-Bicêtre, 94276, France.
authors.forename: Jérôme
authors.initials: J
authors.lastname: Nevoux
authors.forename: Say
authors.initials: S
authors.lastname: Viengchareun
authors.forename: Ingrid
authors.initials: I
authors.lastname: Lema
authors.forename: Anne-Lise
authors.initials: AL
authors.lastname: Lecoq
authors.forename: Evelyne
authors.initials: E
authors.lastname: Ferrary
authors.forename: Marc
authors.initials: M
authors.lastname: Lombès
mesh_terms: D000327:Adsorption; D000818:Animals; D051400:Aquaporin 3 / Q000096:biosynthesis* / Q000187:drug effects; D015153:Blotting, Western; D002478:Cells, Cultured; D003907:Dexamethasone / Q000494:pharmacology; D007758:Ear, Inner / Q000187:drug effects* / Q000378:metabolism; D004710:Endolymph / Q000187:drug effects / Q000378:metabolism*; D005938:Glucocorticoids / Q000494:pharmacology*; D006801:Humans; D007150:Immunohistochemistry; D051379:Mice; D018613:Microscopy, Confocal; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014867:Water / Q000378:metabolism*
chemical_list: D005938:Glucocorticoids; D014867:Water; D051400:Aquaporin 3; D003907:Dexamethasone